[ad_1]
Pfizer Inc. is experiencing a provide scarcity of penicillin within the U.S. amidst elevated demand, however the pharmaceutical firm mentioned Canada ought to be unaffected by the shortage of provide, for now.
The availability scarcity is because of a rise in demand as syphilis an infection charges rise “in addition to aggressive shortages,” Pfizer mentioned in a letter to clients on June 12.
In an e-mail to CTVNews.ca, Christina Antoniou, director affairs at Pfizer Canada, mentioned Friday they’re monitoring the state of affairs “carefully” and it “just isn’t presently impacting Canada.”
Within the letter to U.S. clients, the pharmaceutical and biotechnology firm mentioned chosen gadgets like Bicillin L-A and Bicillin C-R prefilled syringes – Pfizer’s model identify of injectable penicillin – won’t be out there within the U.S. till additional discover.
Penicillin is an antibiotic used to deal with numerous varieties of sicknesses, together with pneumonia and sexually transmitted infections similar to syphilis.
Syphilis circumstances on the rise in Canada
Over the past 5 years, syphilis has made a world resurgence, and Canada has been an outlier amongst rich nations in its charge enhance with a 13-fold over 5 years, in keeping with Well being Canada.
There have been 2,677 circumstances of congenital syphilis within the U.S. in 2021 for a inhabitants of 332 million, in keeping with preliminary CDC knowledge. Canada had 96 circumstances for a inhabitants of 38 million, in keeping with Well being Canada.
CTVNews.ca reached out to Well being Canada to study extra concerning the state of affairs and the Pfizer provide scarcity.
–with information from Reuters
[ad_2]
Source link
